Enliven Therapeutics
ELVN • NASDAQ
Enliven Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Richard A. Fair, with a market cap of $2.7B.
Market Cap$2.7B
Employees50.0
CEORichard A. Fair
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 13, 2026 · in a monthQ1 2026
Financials
Enliven Therapeutics FAQ
Common questions about Enliven Therapeutics
Enliven Therapeutics is scheduled to report earnings for Q1 2026 on May 13, 2026. Analysts estimate revenue of $10.0K.
Enliven Therapeutics has approximately 50 employees.